168 followers
The authors of "Context-Dependent Immunomodulatory Effects of MEK…" (https://t.co/9wabB6XX7b) included RRIDs in their paper! Thank you for making your #methodsmatter. #reproducibility
703 followers
@anruggieri @LesinskiLab
3,878 followers
Tumor-mediated and tumor-independent mechanisms of #MEK inhibitor immunomodulation are ID'd. Read here on how these mechanisms impact #Tcell activity and #AntitumorResponses. https://t.co/vpH3Sgk7Hr. @anruggieri @LesinskiLa https://t.co/rZUGgRttfP
1,232 followers
Today's research highlight is the work of Skylar Woolman, @WVSOM Class of 2024, who co-authored “Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced With T-Cell Agonist Therapy,” published in the journal “Cancer Immunology Research.”
12,413 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
117 followers
RT @DrEzraCohen: MEK inhibition has anti-proliferative effects on both cancer and T cells. The latter can be negated by T cell stimulatory…
1,498 followers
MEK inhibition has anti-proliferative effects on both cancer and T cells. The latter can be negated by T cell stimulatory agonists, e.g. 41BB. Could be time to revisit MEK inhibitors and IO. https://t.co/Es8zIzUEQP
13,915 followers
In this research, investigators suggest that T cell-agonist therapy maximizes the beneficial effects of MEK inhibition on the #antitumor #immune response. https://t.co/aZxbNxzh90 https://t.co/MzaHCHPgCU
2 followers
Context-Dependent Immunomodulatory Effects of MEK Inhibition are Enhanced with T-cell Agonist Therapy https://t.co/vnHwBsNBmP
531 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
652 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
145 followers
RT @jleathe3: And the lab keeps chugging along.
69 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
581 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
350 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
62 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
148 followers
And the lab keeps chugging along.
843 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
906 followers
New article: Context-Dependent Immunomodulatory Effects of MEK Inhibition are Enhanced with T-cell Agonist Therapy https://t.co/Vldg1AJnSe #colorectalcancer #oncology https://t.co/xZmbUbTAVq
426 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
1,459 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
273 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
173 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
706 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
706 followers
RT @LesinskiLab: Great collaboration with @MarkYarchoan @hopkinskimmel @WinshipAtEmory https://t.co/nDoaEZ931J
26 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
38 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
462 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
145 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
1,034 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
1,222 followers
RT @LesinskiLab: Great collaboration with @MarkYarchoan @hopkinskimmel @WinshipAtEmory
10,143 followers
RT @LesinskiLab: Great collaboration with @MarkYarchoan @hopkinskimmel @WinshipAtEmory
4,363 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
313 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
1,713 followers
Great collaboration with @MarkYarchoan @hopkinskimmel @WinshipAtEmory
1,713 followers
RT @MarkYarchoan: Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi…
1,631 followers
Excited to share our newest work on effects of MEK inhibition on the TME, published today in CIR: https://t.co/EWz7hMKloi 👇Summary & rationale for upcoming study of cobimetinib + atezolizumab + T cell agonist trial in #cholangiocarcinoma https://t.co/